{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:29:02Z","timestamp":1773901742446,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science and Technology (COST), COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"},{"name":"European Cooperation in Science & Technology under the COST Action 17138"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41409-022-01733-3","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T08:03:22Z","timestamp":1654934602000},"page":"1458-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-1738","authenticated-orcid":false,"given":"Vladimir","family":"Perovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-8528","authenticated-orcid":false,"given":"Ivan","family":"Sabol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6178-8418","authenticated-orcid":false,"given":"Magdalena","family":"Grce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Inngjerdingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drazen","family":"Pulanic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-8025","authenticated-orcid":false,"given":"Zinaida","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-0088","authenticated-orcid":false,"given":"Christophe","family":"Peczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Polge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-1735","authenticated-orcid":false,"given":"Christian","family":"Koenecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-802X","authenticated-orcid":false,"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Scherwath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-5920","authenticated-orcid":false,"given":"Anna","family":"Barata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attilio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-4735","authenticated-orcid":false,"given":"Anita","family":"Lawitschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-2206","authenticated-orcid":false,"given":"Patrycja","family":"Mensah-Glanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajnalka","family":"Andrikovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-8239","authenticated-orcid":false,"given":"Helene","family":"Schoemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"1733_CR1","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/s41409-019-0465-9","volume":"54","author":"JR Passweg","year":"2019","unstructured":"Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transpl. 2019;54:1575\u201385. https:\/\/doi.org\/10.1038\/s41409-019-0465-9.","journal-title":"Bone Marrow Transpl"},{"key":"1733_CR2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","volume":"21","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transpl. 2015;21:984\u201399. https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.025.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1733_CR3","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","volume":"4","author":"O Penack","year":"2020","unstructured":"Penack O, Peczynski C, Mohty M, Yakoub-Agha I, Styczynski J, Montoto S, et al. How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv. 2020;4:6283\u201390. https:\/\/doi.org\/10.1182\/bloodadvances.2020003418.","journal-title":"Blood Adv"},{"key":"1733_CR4","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","volume":"19","author":"NS Majhail","year":"2013","unstructured":"Majhail NS, Tao L, Bredeson C, Davies S, Dehn J, Gajewski JL, et al. Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transpl. 2013;19:1498\u2013501. https:\/\/doi.org\/10.1016\/j.bbmt.2013.07.020.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1733_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/bmt.2013.129","volume":"49","author":"RF Duarte","year":"2014","unstructured":"Duarte RF, Greinix H, Rabin B, Mitchell SA, Basak G, Wolff D, et al. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. Bone Marrow Transpl. 2014;49:49\u201354. https:\/\/doi.org\/10.1038\/bmt.2013.129.","journal-title":"Bone Marrow Transpl"},{"key":"1733_CR6","doi-asserted-by":"publisher","first-page":"602547","DOI":"10.3389\/fimmu.2020.602547","volume":"11","author":"RE Crossland","year":"2020","unstructured":"Crossland RE, Perutelli F, Bogunia-Kubik K, Mooney N, Milutin Gasperov N, Pucic-Bakovic M, et al. Potential novel biomarkers in chronic graft-versus-host disease. Front Immunol. 2020;11:602547. https:\/\/doi.org\/10.3389\/fimmu.2020.602547.","journal-title":"Front Immunol"},{"key":"1733_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.bbmt.2018.01.029","volume":"24","author":"LJ Burns","year":"2018","unstructured":"Burns LJ, Abbetti B, Arnold SD, Bender J, Doughtie S, El-Jawahiri A, et al. Engaging patients in setting a patient-centered outcomes research agenda in hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2018;24:1111\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.029.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1733_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbmt.2016.09.011","volume":"23","author":"M Bevans","year":"2017","unstructured":"Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National institutes of health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transpl. 2017;23:538\u201351. https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.011.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1733_CR9","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.bbmt.2019.02.017","volume":"25","author":"HM Schoemans","year":"2019","unstructured":"Schoemans HM, Finn L, Foster J, Roche-Green A, Bevans M, Kullberg S, et al. A conceptual framework and key research questions in educational needs of blood and marrow transplantation patients, caregivers, and families. Biol Blood Marrow Transpl. 2019;25:1416\u201323. https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.017.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01733-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01733-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01733-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T15:04:52Z","timestamp":1662131092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01733-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1733"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01733-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DW received honoraria from Novartis, Mallinckrodt, MACO, Janssen, Behring and Incyte. Between 2017 and 2021, H.S. has participated in the Advisory Boards for Incyte, Janssen & Novartis; received speaker\u2019s fees from Novartis, Incyte, Jazz Pharmaceuticals, Takeda and the BHS (Belgian Haematological Society); received travel grants from the EBMT, the CIBMTR, Celgene, Abbvie, Incyte & Gilead and research funding from Novartis and the BHS. All other authors declare no conflict of interest. OP has received honoraria or travel support from Astellas, Gilead, Jazz, MSD, Neovii Biotech, Novartis, Pfizer and Therakos. He has received research support from Gilead, Incyte, Jazz, Neovii Biotech and Takeda. He is a member of advisory boards to Jazz, Gilead, MSD, Omeros, Priothera, Shionogi and SOBI. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}